Industry Research Reports
Home > Reports > Pharma & Healthcare > Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 95 Pages
Report ld: 3479945
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Urokinase Market Size(US$)
CAGR 2025-2031
5.2%
Market Size,2031
USD 70.6
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 52.1 million
Market Forecast in 2031(Value)
US$ 70.6 million
CAGR
5.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.
This report aims to provide a comprehensive presentation of the global market for Urokinase, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Urokinase by region & country, by Type, and by Application.
The Urokinase market size, estimations, and forecasts are provided in terms of sales volume (BIU) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urokinase.
MARKET SEGMENTATION
By Company
- Syner-Med
- Wanhua Biochem
- Jiangxi Haoran Bio-Pharma
- Jiangsu Aidea Pharmaceutical
- Techpool
- Microbic Biosystems
- LIVZON
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Urokinase Powder
- Urokinase Solution
Segment by Application
- Hospital
- Clinic
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Urokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Urokinase in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Urokinase Product Introduction
1.2 Global Urokinase Market Size Forecast
1.2.1 Global Urokinase Sales Value (2020-2031)
1.2.2 Global Urokinase Sales Volume (2020-2031)
1.2.3 Global Urokinase Sales Price (2020-2031)
1.3 Urokinase Market Trends & Drivers
1.3.1 Urokinase Industry Trends
1.3.2 Urokinase Market Drivers & Opportunity
1.3.3 Urokinase Market Challenges
1.3.4 Urokinase Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Urokinase Players Revenue Ranking (2024)
2.2 Global Urokinase Revenue by Company (2020-2025)
2.3 Global Urokinase Players Sales Volume Ranking (2024)
2.4 Global Urokinase Sales Volume by Company Players (2020-2025)
2.5 Global Urokinase Average Price by Company (2020-2025)
2.6 Key Manufacturers Urokinase Manufacturing Base and Headquarters
2.7 Key Manufacturers Urokinase Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Urokinase
2.9 Urokinase Market Competitive Analysis
2.9.1 Urokinase Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Urokinase Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urokinase as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Urokinase Powder
3.1.2 Urokinase Solution
3.2 Global Urokinase Sales Value by Type
3.2.1 Global Urokinase Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Urokinase Sales Value, by Type (2020-2031)
3.2.3 Global Urokinase Sales Value, by Type (%) (2020-2031)
3.3 Global Urokinase Sales Volume by Type
3.3.1 Global Urokinase Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Urokinase Sales Volume, by Type (2020-2031)
3.3.3 Global Urokinase Sales Volume, by Type (%) (2020-2031)
3.4 Global Urokinase Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Urokinase Sales Value by Application
4.2.1 Global Urokinase Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Urokinase Sales Value, by Application (2020-2031)
4.2.3 Global Urokinase Sales Value, by Application (%) (2020-2031)
4.3 Global Urokinase Sales Volume by Application
4.3.1 Global Urokinase Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Urokinase Sales Volume, by Application (2020-2031)
4.3.3 Global Urokinase Sales Volume, by Application (%) (2020-2031)
4.4 Global Urokinase Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Urokinase Sales Value by Region
5.1.1 Global Urokinase Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Urokinase Sales Value by Region (2020-2025)
5.1.3 Global Urokinase Sales Value by Region (2026-2031)
5.1.4 Global Urokinase Sales Value by Region (%), (2020-2031)
5.2 Global Urokinase Sales Volume by Region
5.2.1 Global Urokinase Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Urokinase Sales Volume by Region (2020-2025)
5.2.3 Global Urokinase Sales Volume by Region (2026-2031)
5.2.4 Global Urokinase Sales Volume by Region (%), (2020-2031)
5.3 Global Urokinase Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Urokinase Sales Value, 2020-2031
5.4.2 North America Urokinase Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Urokinase Sales Value, 2020-2031
5.5.2 Europe Urokinase Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Urokinase Sales Value, 2020-2031
5.6.2 Asia Pacific Urokinase Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Urokinase Sales Value, 2020-2031
5.7.2 South America Urokinase Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Urokinase Sales Value, 2020-2031
5.8.2 Middle East & Africa Urokinase Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Urokinase Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Urokinase Sales Value
6.2.1 Key Countries/Regions Urokinase Sales Value, 2020-2031
6.2.2 Key Countries/Regions Urokinase Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Urokinase Sales Value, 2020-2031
6.3.2 United States Urokinase Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Urokinase Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Urokinase Sales Value, 2020-2031
6.4.2 Europe Urokinase Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Urokinase Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Urokinase Sales Value, 2020-2031
6.5.2 China Urokinase Sales Value by Type (%), 2024 VS 2031
6.5.3 China Urokinase Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Urokinase Sales Value, 2020-2031
6.6.2 Japan Urokinase Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Urokinase Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Urokinase Sales Value, 2020-2031
6.7.2 South Korea Urokinase Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Urokinase Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Urokinase Sales Value, 2020-2031
6.8.2 Southeast Asia Urokinase Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Urokinase Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Urokinase Sales Value, 2020-2031
6.9.2 India Urokinase Sales Value by Type (%), 2024 VS 2031
6.9.3 India Urokinase Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Syner-Med
7.1.1 Syner-Med Company Information
7.1.2 Syner-Med Introduction and Business Overview
7.1.3 Syner-Med Urokinase Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Syner-Med Urokinase Product Offerings
7.1.5 Syner-Med Recent Development
7.2 Wanhua Biochem
7.2.1 Wanhua Biochem Company Information
7.2.2 Wanhua Biochem Introduction and Business Overview
7.2.3 Wanhua Biochem Urokinase Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Wanhua Biochem Urokinase Product Offerings
7.2.5 Wanhua Biochem Recent Development
7.3 Jiangxi Haoran Bio-Pharma
7.3.1 Jiangxi Haoran Bio-Pharma Company Information
7.3.2 Jiangxi Haoran Bio-Pharma Introduction and Business Overview
7.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Jiangxi Haoran Bio-Pharma Urokinase Product Offerings
7.3.5 Jiangxi Haoran Bio-Pharma Recent Development
7.4 Jiangsu Aidea Pharmaceutical
7.4.1 Jiangsu Aidea Pharmaceutical Company Information
7.4.2 Jiangsu Aidea Pharmaceutical Introduction and Business Overview
7.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Jiangsu Aidea Pharmaceutical Urokinase Product Offerings
7.4.5 Jiangsu Aidea Pharmaceutical Recent Development
7.5 Techpool
7.5.1 Techpool Company Information
7.5.2 Techpool Introduction and Business Overview
7.5.3 Techpool Urokinase Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Techpool Urokinase Product Offerings
7.5.5 Techpool Recent Development
7.6 Microbic Biosystems
7.6.1 Microbic Biosystems Company Information
7.6.2 Microbic Biosystems Introduction and Business Overview
7.6.3 Microbic Biosystems Urokinase Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Microbic Biosystems Urokinase Product Offerings
7.6.5 Microbic Biosystems Recent Development
7.7 LIVZON
7.7.1 LIVZON Company Information
7.7.2 LIVZON Introduction and Business Overview
7.7.3 LIVZON Urokinase Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 LIVZON Urokinase Product Offerings
7.7.5 LIVZON Recent Development
8 Industry Chain Analysis
8.1 Urokinase Industrial Chain
8.2 Urokinase Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Urokinase Sales Model
8.5.2 Sales Channel
8.5.3 Urokinase Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Urokinase Market Trends
Table 2. Urokinase Market Drivers & Opportunity
Table 3. Urokinase Market Challenges
Table 4. Urokinase Market Restraints
Table 5. Global Urokinase Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Urokinase Revenue Market Share by Company (2020-2025)
Table 7. Global Urokinase Sales Volume by Company (2020-2025) & (BIU)
Table 8. Global Urokinase Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Urokinase Price by Company (2020-2025) & (US$/MIU)
Table 10. Key Manufacturers Urokinase Manufacturing Base and Headquarters
Table 11. Key Manufacturers Urokinase Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Urokinase
Table 13. Global Urokinase Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urokinase as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Urokinase Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Urokinase Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Urokinase Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Urokinase Sales Market Share in Value by Type (2020-2025)
Table 20. Global Urokinase Sales Market Share in Value by Type (2026-2031)
Table 21. Global Urokinase Sales Volume by Type: 2020 VS 2024 VS 2031 (BIU)
Table 22. Global Urokinase Sales Volume by Type (2020-2025) & (BIU)
Table 23. Global Urokinase Sales Volume by Type (2026-2031) & (BIU)
Table 24. Global Urokinase Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Urokinase Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Urokinase Price by Type (2020-2025) & (US$/MIU)
Table 27. Global Urokinase Price by Type (2026-2031) & (US$/MIU)
Table 28. Global Urokinase Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Urokinase Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Urokinase Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Urokinase Sales Market Share in Value by Application (2020-2025)
Table 32. Global Urokinase Sales Market Share in Value by Application (2026-2031)
Table 33. Global Urokinase Sales Volume by Application: 2020 VS 2024 VS 2031 (BIU)
Table 34. Global Urokinase Sales Volume by Application (2020-2025) & (BIU)
Table 35. Global Urokinase Sales Volume by Application (2026-2031) & (BIU)
Table 36. Global Urokinase Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Urokinase Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Urokinase Price by Application (2020-2025) & (US$/MIU)
Table 39. Global Urokinase Price by Application (2026-2031) & (US$/MIU)
Table 40. Global Urokinase Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Urokinase Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Urokinase Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Urokinase Sales Value by Region (2020-2025) & (%)
Table 44. Global Urokinase Sales Value by Region (2026-2031) & (%)
Table 45. Global Urokinase Sales Volume by Region (BIU): 2020 VS 2024 VS 2031
Table 46. Global Urokinase Sales Volume by Region (2020-2025) & (BIU)
Table 47. Global Urokinase Sales Volume by Region (2026-2031) & (BIU)
Table 48. Global Urokinase Sales Volume by Region (2020-2025) & (%)
Table 49. Global Urokinase Sales Volume by Region (2026-2031) & (%)
Table 50. Global Urokinase Average Price by Region (2020-2025) & (US$/MIU)
Table 51. Global Urokinase Average Price by Region (2026-2031) & (US$/MIU)
Table 52. Key Countries/Regions Urokinase Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Urokinase Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Urokinase Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Urokinase Sales Volume, (2020-2025) & (BIU)
Table 56. Key Countries/Regions Urokinase Sales Volume, (2026-2031) & (BIU)
Table 57. Syner-Med Company Information
Table 58. Syner-Med Introduction and Business Overview
Table 59. Syner-Med Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)
Table 60. Syner-Med Urokinase Product Offerings
Table 61. Syner-Med Recent Development
Table 62. Wanhua Biochem Company Information
Table 63. Wanhua Biochem Introduction and Business Overview
Table 64. Wanhua Biochem Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)
Table 65. Wanhua Biochem Urokinase Product Offerings
Table 66. Wanhua Biochem Recent Development
Table 67. Jiangxi Haoran Bio-Pharma Company Information
Table 68. Jiangxi Haoran Bio-Pharma Introduction and Business Overview
Table 69. Jiangxi Haoran Bio-Pharma Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)
Table 70. Jiangxi Haoran Bio-Pharma Urokinase Product Offerings
Table 71. Jiangxi Haoran Bio-Pharma Recent Development
Table 72. Jiangsu Aidea Pharmaceutical Company Information
Table 73. Jiangsu Aidea Pharmaceutical Introduction and Business Overview
Table 74. Jiangsu Aidea Pharmaceutical Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)
Table 75. Jiangsu Aidea Pharmaceutical Urokinase Product Offerings
Table 76. Jiangsu Aidea Pharmaceutical Recent Development
Table 77. Techpool Company Information
Table 78. Techpool Introduction and Business Overview
Table 79. Techpool Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)
Table 80. Techpool Urokinase Product Offerings
Table 81. Techpool Recent Development
Table 82. Microbic Biosystems Company Information
Table 83. Microbic Biosystems Introduction and Business Overview
Table 84. Microbic Biosystems Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)
Table 85. Microbic Biosystems Urokinase Product Offerings
Table 86. Microbic Biosystems Recent Development
Table 87. LIVZON Company Information
Table 88. LIVZON Introduction and Business Overview
Table 89. LIVZON Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)
Table 90. LIVZON Urokinase Product Offerings
Table 91. LIVZON Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Urokinase Downstream Customers
Table 95. Urokinase Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Urokinase Product Picture
Figure 2. Global Urokinase Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Urokinase Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Urokinase Sales Volume (2020-2031) & (BIU)
Figure 5. Global Urokinase Sales Price (2020-2031) & (US$/MIU)
Figure 6. Urokinase Report Years Considered
Figure 7. Global Urokinase Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Urokinase Players Sales Volume Ranking (2024) & (BIU)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Urokinase Revenue in 2024
Figure 10. Urokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Urokinase Powder Picture
Figure 12. Urokinase Solution Picture
Figure 13. Global Urokinase Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Urokinase Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Urokinase Sales Volume by Type (2020 VS 2024 VS 2031) & (BIU)
Figure 16. Global Urokinase Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Urokinase Price by Type (2020-2031) & (US$/MIU)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Others
Figure 21. Global Urokinase Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Urokinase Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Urokinase Sales Volume by Application (2020 VS 2024 VS 2031) & (BIU)
Figure 24. Global Urokinase Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Urokinase Price by Application (2020-2031) & (US$/MIU)
Figure 26. North America Urokinase Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Urokinase Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Urokinase Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Urokinase Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Urokinase Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Urokinase Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Urokinase Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Urokinase Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Urokinase Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Urokinase Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Urokinase Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Urokinase Sales Volume (%), (2020-2031)
Figure 38. United States Urokinase Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Urokinase Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Urokinase Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Urokinase Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Urokinase Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Urokinase Sales Value by Application (%), 2024 VS 2031
Figure 44. China Urokinase Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Urokinase Sales Value by Type (%), 2024 VS 2031
Figure 46. China Urokinase Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Urokinase Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Urokinase Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Urokinase Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Urokinase Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Urokinase Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Urokinase Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Urokinase Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Urokinase Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Urokinase Sales Value by Application (%), 2024 VS 2031
Figure 56. India Urokinase Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Urokinase Sales Value by Type (%), 2024 VS 2031
Figure 58. India Urokinase Sales Value by Application (%), 2024 VS 2031
Figure 59. Urokinase Industrial Chain
Figure 60. Urokinase Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Urokinase market?
The top companies in the global Urokinase market are Syner-Med、Wanhua Biochem、Jiangxi Haoran Bio-Pharma.
Which region is expected to have the highest market share?
What was the global market size of Urokinase in 2025?
What is the annual compound growth rate of the global Urokinase market size from 2025 to 2031?
What was the global market size of Urokinase in 2031?
Related Reports
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 116
USD 2900.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 3950.00
(Single User License)
Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 147
USD 4900.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 121
USD 5900.00
(Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 79
USD 4250.00
(Single User License)
Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-01-16
Pages: 79
USD 2900.00
(Single User License)
Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-07
Pages: 89
USD 4900.00
(Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
USD 4250.00 (Single User License)Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 116
USD 2900.00 (Single User License)Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 3950.00 (Single User License)Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 147
USD 4900.00 (Single User License)Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 121
USD 5900.00 (Single User License)Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 79
USD 4250.00 (Single User License)Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-01-16
Pages: 79
USD 2900.00 (Single User License)Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-07
Pages: 89
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now